Impact of medication adherence to disease-modifying drugs on severe relapse, and direct and indirect costs among employees with multiple sclerosis in U.S.
J Med Econ. 2012;15(3):601-9
Authors
Ivanova J, Bergman R, Birnbaum H, Phillips A, Stewart M, Meletiche D